Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 72 | 2024 | 1890 | 8.270 |
Why?
|
Sleep Apnea Syndromes | 43 | 2024 | 981 | 5.560 |
Why?
|
Continuous Positive Airway Pressure | 31 | 2024 | 578 | 5.370 |
Why?
|
Polysomnography | 54 | 2024 | 1864 | 2.620 |
Why?
|
Restless Legs Syndrome | 5 | 2017 | 235 | 1.440 |
Why?
|
Sleep | 30 | 2021 | 4796 | 1.380 |
Why?
|
Oxyhemoglobins | 8 | 2020 | 213 | 1.300 |
Why?
|
Cardiovascular Diseases | 31 | 2023 | 15638 | 1.280 |
Why?
|
Disorders of Excessive Somnolence | 7 | 2022 | 277 | 1.230 |
Why?
|
Angiopoietin-2 | 3 | 2024 | 173 | 0.920 |
Why?
|
Sleep Apnea, Central | 4 | 2017 | 88 | 0.830 |
Why?
|
Patient Compliance | 5 | 2024 | 2696 | 0.730 |
Why?
|
Automobile Driving | 2 | 2020 | 449 | 0.730 |
Why?
|
Vital Capacity | 10 | 2009 | 984 | 0.660 |
Why?
|
Antigens, CD1d | 1 | 2020 | 225 | 0.660 |
Why?
|
Hypertension | 13 | 2024 | 8611 | 0.660 |
Why?
|
Sleep, REM | 5 | 2018 | 595 | 0.650 |
Why?
|
Pulmonary Valve | 3 | 2013 | 413 | 0.640 |
Why?
|
rab GTP-Binding Proteins | 1 | 2020 | 244 | 0.620 |
Why?
|
Sleep Deprivation | 4 | 2018 | 848 | 0.500 |
Why?
|
Humans | 208 | 2024 | 768451 | 0.500 |
Why?
|
Medicare | 26 | 2024 | 6881 | 0.490 |
Why?
|
Forced Expiratory Volume | 10 | 2016 | 1820 | 0.490 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2017 | 417 | 0.470 |
Why?
|
Male | 144 | 2024 | 364781 | 0.450 |
Why?
|
Pleura | 1 | 2015 | 248 | 0.450 |
Why?
|
Middle Aged | 106 | 2024 | 223418 | 0.430 |
Why?
|
Female | 143 | 2024 | 396943 | 0.430 |
Why?
|
Down-Regulation | 1 | 2020 | 2944 | 0.420 |
Why?
|
Accidents, Traffic | 1 | 2018 | 821 | 0.400 |
Why?
|
Aged | 100 | 2024 | 171520 | 0.400 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 8 | 2023 | 3246 | 0.400 |
Why?
|
Genetic Linkage | 5 | 2019 | 2342 | 0.380 |
Why?
|
Hospitals, Veterans | 3 | 2009 | 395 | 0.370 |
Why?
|
Cohort Studies | 44 | 2023 | 41797 | 0.360 |
Why?
|
Coronary Disease | 3 | 2019 | 5926 | 0.360 |
Why?
|
Glucose Intolerance | 4 | 2013 | 579 | 0.360 |
Why?
|
Risk Factors | 43 | 2024 | 74915 | 0.360 |
Why?
|
Elastin | 4 | 2000 | 299 | 0.360 |
Why?
|
Polymorphism, Single Nucleotide | 20 | 2024 | 16029 | 0.340 |
Why?
|
Cross-Sectional Studies | 36 | 2023 | 26351 | 0.340 |
Why?
|
Pulmonary Artery | 3 | 2013 | 1949 | 0.340 |
Why?
|
Respiration | 6 | 2016 | 1667 | 0.340 |
Why?
|
Central Nervous System Depressants | 1 | 2010 | 164 | 0.340 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2005 | 881 | 0.340 |
Why?
|
Regional Medical Programs | 1 | 2010 | 66 | 0.330 |
Why?
|
Aorta | 3 | 2016 | 2046 | 0.320 |
Why?
|
Circadian Rhythm | 6 | 2023 | 2585 | 0.320 |
Why?
|
Health Expenditures | 9 | 2014 | 2391 | 0.320 |
Why?
|
Sleep Stages | 7 | 2013 | 702 | 0.310 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 12774 | 0.310 |
Why?
|
Electrocardiography | 6 | 2014 | 6410 | 0.310 |
Why?
|
Sheep | 6 | 2013 | 1451 | 0.300 |
Why?
|
Brachial Artery | 1 | 2009 | 373 | 0.300 |
Why?
|
Pulmonary Veins | 1 | 2014 | 755 | 0.290 |
Why?
|
Expert Systems | 1 | 2007 | 79 | 0.290 |
Why?
|
Quality of Life | 11 | 2024 | 13497 | 0.280 |
Why?
|
Genome, Human | 6 | 2021 | 4453 | 0.280 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3637 | 0.280 |
Why?
|
Apolipoproteins E | 2 | 2021 | 1461 | 0.280 |
Why?
|
Atherosclerosis | 2 | 2023 | 3431 | 0.280 |
Why?
|
Respiration Disorders | 2 | 2016 | 367 | 0.280 |
Why?
|
Blood Pressure | 10 | 2024 | 8538 | 0.270 |
Why?
|
Managed Competition | 1 | 2006 | 33 | 0.270 |
Why?
|
Adult | 69 | 2024 | 223542 | 0.270 |
Why?
|
Vasodilation | 2 | 2013 | 968 | 0.270 |
Why?
|
Ventricular Remodeling | 1 | 2014 | 1280 | 0.260 |
Why?
|
Caffeine | 1 | 2010 | 702 | 0.260 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2008 | 857 | 0.260 |
Why?
|
Systole | 1 | 2008 | 938 | 0.260 |
Why?
|
Prospective Studies | 25 | 2022 | 54914 | 0.260 |
Why?
|
Blood Glucose | 8 | 2022 | 6429 | 0.250 |
Why?
|
Health Surveys | 7 | 2015 | 4056 | 0.250 |
Why?
|
Snoring | 3 | 2003 | 209 | 0.250 |
Why?
|
Genetic Loci | 4 | 2021 | 2630 | 0.250 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2003 | 370 | 0.250 |
Why?
|
Insurance Benefits | 2 | 2017 | 187 | 0.240 |
Why?
|
Lung Diseases | 1 | 2015 | 1926 | 0.240 |
Why?
|
Spirometry | 9 | 2021 | 928 | 0.240 |
Why?
|
Wakefulness | 4 | 2021 | 1280 | 0.240 |
Why?
|
Desmosine | 4 | 2000 | 19 | 0.230 |
Why?
|
Melatonin | 2 | 2023 | 669 | 0.230 |
Why?
|
Ethanol | 1 | 2010 | 1334 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2021 | 12242 | 0.230 |
Why?
|
Aged, 80 and over | 40 | 2021 | 59680 | 0.230 |
Why?
|
Reaction Time | 1 | 2010 | 2102 | 0.230 |
Why?
|
Apolipoprotein E4 | 3 | 2022 | 712 | 0.230 |
Why?
|
Social Responsibility | 1 | 2006 | 385 | 0.220 |
Why?
|
Bottle Feeding | 1 | 2004 | 67 | 0.220 |
Why?
|
Postoperative Complications | 4 | 2018 | 15880 | 0.220 |
Why?
|
Interleukin-6 | 3 | 2021 | 3234 | 0.220 |
Why?
|
CLOCK Proteins | 2 | 2014 | 87 | 0.220 |
Why?
|
Transposition of Great Vessels | 1 | 2008 | 580 | 0.220 |
Why?
|
Tissue Engineering | 3 | 2010 | 1890 | 0.220 |
Why?
|
Hospitals | 4 | 2022 | 3906 | 0.220 |
Why?
|
Hares | 1 | 2023 | 4 | 0.220 |
Why?
|
Efficiency, Organizational | 2 | 2009 | 699 | 0.220 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2021 | 1097 | 0.220 |
Why?
|
Oxygen | 12 | 2024 | 4269 | 0.220 |
Why?
|
Longitudinal Studies | 12 | 2021 | 14766 | 0.210 |
Why?
|
Fee-for-Service Plans | 5 | 2017 | 714 | 0.210 |
Why?
|
Odds Ratio | 11 | 2016 | 9687 | 0.210 |
Why?
|
Referral and Consultation | 5 | 2021 | 3629 | 0.210 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2021 | 325 | 0.210 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2007 | 712 | 0.210 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2013 | 1496 | 0.200 |
Why?
|
Medical Staff, Hospital | 1 | 2006 | 603 | 0.200 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2022 | 48 | 0.200 |
Why?
|
United States | 43 | 2024 | 73121 | 0.200 |
Why?
|
Lung | 7 | 2023 | 10090 | 0.200 |
Why?
|
Heart Diseases | 1 | 2015 | 2816 | 0.200 |
Why?
|
Metalloproteases | 1 | 2022 | 61 | 0.200 |
Why?
|
Respiratory Function Tests | 6 | 2021 | 1697 | 0.200 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 1180 | 0.200 |
Why?
|
Heart Valves | 2 | 2017 | 284 | 0.200 |
Why?
|
Arousal | 4 | 2023 | 1182 | 0.200 |
Why?
|
Severity of Illness Index | 18 | 2024 | 15965 | 0.190 |
Why?
|
Lung Diseases, Interstitial | 2 | 2023 | 935 | 0.190 |
Why?
|
Veterans | 3 | 2023 | 2671 | 0.190 |
Why?
|
Collagen | 4 | 2013 | 2646 | 0.190 |
Why?
|
Health Services Accessibility | 6 | 2015 | 5510 | 0.190 |
Why?
|
Body Mass Index | 17 | 2024 | 13030 | 0.190 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5887 | 0.190 |
Why?
|
Heart Rate | 5 | 2024 | 4218 | 0.190 |
Why?
|
Heart Ventricles | 1 | 2014 | 3839 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 2 | 2024 | 1036 | 0.190 |
Why?
|
Risk Adjustment | 4 | 2018 | 603 | 0.180 |
Why?
|
Heart Failure | 3 | 2019 | 11857 | 0.180 |
Why?
|
Comorbidity | 11 | 2018 | 10601 | 0.180 |
Why?
|
Stroke | 5 | 2019 | 9791 | 0.180 |
Why?
|
Osteopontin | 1 | 2022 | 307 | 0.170 |
Why?
|
Catheter Ablation | 1 | 2014 | 2775 | 0.170 |
Why?
|
Attention | 1 | 2010 | 2423 | 0.170 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2000 | 112 | 0.170 |
Why?
|
alpha 1-Antitrypsin | 1 | 2000 | 169 | 0.170 |
Why?
|
Heme | 1 | 2022 | 316 | 0.170 |
Why?
|
Sex Characteristics | 4 | 2021 | 2666 | 0.170 |
Why?
|
Mandibular Advancement | 1 | 2020 | 64 | 0.170 |
Why?
|
Alcoholic Intoxication | 2 | 2011 | 176 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 10 | 2024 | 18048 | 0.170 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 18 | 0.170 |
Why?
|
Intelligence | 1 | 2004 | 929 | 0.160 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 5162 | 0.160 |
Why?
|
Ferrochelatase | 1 | 2019 | 47 | 0.160 |
Why?
|
Hexokinase | 1 | 2019 | 124 | 0.160 |
Why?
|
Cluster Analysis | 2 | 2023 | 2731 | 0.160 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1727 | 0.160 |
Why?
|
Child Behavior Disorders | 1 | 2003 | 813 | 0.150 |
Why?
|
Cognition | 3 | 2021 | 7066 | 0.150 |
Why?
|
Osteoporotic Fractures | 1 | 2023 | 417 | 0.150 |
Why?
|
Exons | 2 | 2004 | 2392 | 0.150 |
Why?
|
Obesity Hypoventilation Syndrome | 1 | 2018 | 17 | 0.150 |
Why?
|
Fasting | 6 | 2016 | 1608 | 0.150 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2019 | 453 | 0.150 |
Why?
|
Alleles | 7 | 2021 | 6890 | 0.150 |
Why?
|
Adenoids | 2 | 2009 | 35 | 0.140 |
Why?
|
Inflammation | 5 | 2023 | 10865 | 0.140 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2742 | 0.140 |
Why?
|
Linear Models | 11 | 2017 | 5880 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 797 | 0.140 |
Why?
|
Quality Assurance, Health Care | 2 | 2007 | 2179 | 0.140 |
Why?
|
Weight Gain | 3 | 2014 | 2357 | 0.140 |
Why?
|
Health Care Costs | 3 | 2009 | 3265 | 0.140 |
Why?
|
Leukemia, Myeloid | 1 | 2000 | 693 | 0.140 |
Why?
|
Palatine Tonsil | 2 | 2009 | 193 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5426 | 0.140 |
Why?
|
Quality of Health Care | 6 | 2011 | 4340 | 0.140 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2000 | 656 | 0.140 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 471 | 0.130 |
Why?
|
Quantitative Trait Loci | 3 | 2022 | 2127 | 0.130 |
Why?
|
Telemedicine | 2 | 2011 | 3104 | 0.130 |
Why?
|
Fatigue | 1 | 2003 | 1556 | 0.130 |
Why?
|
Memory | 2 | 2012 | 2210 | 0.130 |
Why?
|
Reference Values | 6 | 2008 | 4941 | 0.130 |
Why?
|
Vertebral Artery Dissection | 1 | 2016 | 49 | 0.130 |
Why?
|
Diabetes Complications | 1 | 2003 | 1322 | 0.130 |
Why?
|
Quality Indicators, Health Care | 3 | 2017 | 1813 | 0.130 |
Why?
|
Genotype | 9 | 2021 | 13047 | 0.130 |
Why?
|
Bioprosthesis | 2 | 2010 | 592 | 0.130 |
Why?
|
Antigens, Nuclear | 1 | 2016 | 184 | 0.130 |
Why?
|
Manipulation, Chiropractic | 1 | 2015 | 24 | 0.130 |
Why?
|
Glucose Metabolism Disorders | 1 | 2015 | 52 | 0.130 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 1 | 2015 | 31 | 0.130 |
Why?
|
Obesity | 11 | 2023 | 13065 | 0.130 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2016 | 198 | 0.130 |
Why?
|
Hypertrophy | 2 | 2009 | 562 | 0.120 |
Why?
|
Breast Feeding | 1 | 2004 | 1365 | 0.120 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2016 | 82 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1557 | 0.120 |
Why?
|
Psychomotor Performance | 3 | 2011 | 1894 | 0.120 |
Why?
|
Thoracic Surgical Procedures | 2 | 2016 | 350 | 0.120 |
Why?
|
Cyanosis | 1 | 2015 | 82 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2024 | 65409 | 0.120 |
Why?
|
Blalock-Taussig Procedure | 1 | 2015 | 60 | 0.120 |
Why?
|
Prognosis | 7 | 2021 | 30028 | 0.120 |
Why?
|
Bacteroides Infections | 1 | 2014 | 89 | 0.120 |
Why?
|
Mediastinitis | 1 | 2014 | 49 | 0.120 |
Why?
|
Adrenergic beta-Agonists | 2 | 1995 | 347 | 0.120 |
Why?
|
Health Status | 4 | 2017 | 4096 | 0.120 |
Why?
|
Benchmarking | 1 | 2021 | 1058 | 0.120 |
Why?
|
C-Reactive Protein | 2 | 2019 | 3854 | 0.120 |
Why?
|
Genetic Variation | 5 | 2021 | 6610 | 0.120 |
Why?
|
Chromosomes, Human, Pair 4 | 3 | 2009 | 375 | 0.110 |
Why?
|
Phenotype | 10 | 2022 | 16712 | 0.110 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5367 | 0.110 |
Why?
|
Survival Analysis | 5 | 2016 | 10125 | 0.110 |
Why?
|
Omentum | 1 | 2014 | 168 | 0.110 |
Why?
|
Skin Tests | 1 | 1996 | 639 | 0.110 |
Why?
|
Prospective Payment System | 1 | 2014 | 136 | 0.110 |
Why?
|
Oxygen Consumption | 2 | 2016 | 1882 | 0.110 |
Why?
|
Neck Pain | 1 | 2015 | 190 | 0.110 |
Why?
|
Prevalence | 10 | 2022 | 15880 | 0.110 |
Why?
|
Sternotomy | 1 | 2014 | 132 | 0.110 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 166 | 0.110 |
Why?
|
Time Factors | 16 | 2018 | 40271 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2785 | 0.110 |
Why?
|
Mortality | 4 | 2018 | 2917 | 0.110 |
Why?
|
Statistics as Topic | 3 | 2009 | 2362 | 0.110 |
Why?
|
Calibration | 1 | 2015 | 823 | 0.110 |
Why?
|
Mothers | 1 | 2004 | 2210 | 0.110 |
Why?
|
Receptors, Dopamine D2 | 1 | 2015 | 486 | 0.110 |
Why?
|
Observer Variation | 4 | 2014 | 2622 | 0.100 |
Why?
|
Teratoma | 1 | 2016 | 405 | 0.100 |
Why?
|
Age Distribution | 3 | 2009 | 2881 | 0.100 |
Why?
|
Exercise | 2 | 2020 | 5940 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3520 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2000 | 1357 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2000 | 2003 | 0.100 |
Why?
|
Aging | 3 | 2013 | 8761 | 0.100 |
Why?
|
Sleep Medicine Specialty | 1 | 2012 | 72 | 0.100 |
Why?
|
Phylogeny | 1 | 2019 | 2846 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2004 | 2181 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2009 | 6242 | 0.100 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 143 | 0.100 |
Why?
|
Haplotypes | 3 | 2021 | 2725 | 0.100 |
Why?
|
Heart Valve Prosthesis | 2 | 2010 | 1468 | 0.090 |
Why?
|
Reoperation | 2 | 2015 | 4342 | 0.090 |
Why?
|
Utilization Review | 2 | 2010 | 384 | 0.090 |
Why?
|
Smoking | 6 | 2007 | 9099 | 0.090 |
Why?
|
Back Pain | 1 | 2015 | 547 | 0.090 |
Why?
|
Echocardiography | 4 | 2014 | 5043 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 2 | 1993 | 497 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2016 | 806 | 0.090 |
Why?
|
Geography | 2 | 2011 | 654 | 0.090 |
Why?
|
Healthcare Disparities | 2 | 2017 | 3412 | 0.090 |
Why?
|
Alzheimer Disease | 3 | 2021 | 8721 | 0.090 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6551 | 0.090 |
Why?
|
Proportional Hazards Models | 7 | 2019 | 12561 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 420 | 0.090 |
Why?
|
P-Selectin | 1 | 2013 | 599 | 0.090 |
Why?
|
Beer | 1 | 2010 | 135 | 0.090 |
Why?
|
Models, Economic | 1 | 2014 | 717 | 0.090 |
Why?
|
Insulin Resistance | 4 | 2015 | 3974 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2017 | 39430 | 0.090 |
Why?
|
Incidence | 8 | 2021 | 21552 | 0.090 |
Why?
|
Diagnosis | 1 | 2011 | 156 | 0.090 |
Why?
|
Perioperative Care | 1 | 2018 | 1046 | 0.090 |
Why?
|
Cardiovascular System | 1 | 2017 | 838 | 0.080 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 879 | 0.080 |
Why?
|
Brain Infarction | 2 | 2022 | 290 | 0.080 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2010 | 389 | 0.080 |
Why?
|
Tetralogy of Fallot | 1 | 2015 | 628 | 0.080 |
Why?
|
Proteomics | 1 | 2023 | 3901 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2819 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2013 | 1133 | 0.080 |
Why?
|
Calcium Channel Blockers | 1 | 1992 | 692 | 0.080 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2009 | 239 | 0.080 |
Why?
|
Alcoholic Beverages | 1 | 2011 | 266 | 0.080 |
Why?
|
Hip Fractures | 2 | 2008 | 996 | 0.080 |
Why?
|
Mass Screening | 2 | 2022 | 5455 | 0.080 |
Why?
|
Group Practice | 1 | 2010 | 151 | 0.080 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2014 | 595 | 0.080 |
Why?
|
Prosthesis-Related Infections | 1 | 2014 | 491 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 4049 | 0.080 |
Why?
|
Resistance Training | 1 | 2011 | 199 | 0.080 |
Why?
|
Physicians | 3 | 2021 | 4615 | 0.080 |
Why?
|
Wechsler Scales | 2 | 2011 | 258 | 0.080 |
Why?
|
Work Schedule Tolerance | 1 | 1993 | 553 | 0.080 |
Why?
|
Databases, Factual | 5 | 2017 | 8081 | 0.080 |
Why?
|
Medicare Part B | 1 | 2010 | 117 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3346 | 0.080 |
Why?
|
Health Behavior | 1 | 2020 | 2649 | 0.080 |
Why?
|
Weight Loss | 1 | 2020 | 2710 | 0.080 |
Why?
|
Hyperemia | 1 | 2009 | 225 | 0.080 |
Why?
|
Spinal Cord Injuries | 1 | 2016 | 928 | 0.080 |
Why?
|
Diagnosis-Related Groups | 1 | 2010 | 448 | 0.080 |
Why?
|
Lower Extremity | 1 | 2016 | 1214 | 0.080 |
Why?
|
Allergens | 1 | 1996 | 1445 | 0.070 |
Why?
|
Pacemaker, Artificial | 2 | 2005 | 828 | 0.070 |
Why?
|
Health Resources | 2 | 2017 | 950 | 0.070 |
Why?
|
Pennsylvania | 1 | 2009 | 616 | 0.070 |
Why?
|
Telephone | 1 | 2011 | 630 | 0.070 |
Why?
|
Organ Size | 1 | 2013 | 2268 | 0.070 |
Why?
|
Health Services | 1 | 2013 | 756 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2013 | 986 | 0.070 |
Why?
|
Professional Practice | 1 | 2009 | 314 | 0.070 |
Why?
|
Home Care Services | 2 | 2004 | 655 | 0.070 |
Why?
|
Organ Culture Techniques | 1 | 2009 | 796 | 0.070 |
Why?
|
Logistic Models | 4 | 2018 | 13324 | 0.070 |
Why?
|
Patient Readmission | 3 | 2017 | 3308 | 0.070 |
Why?
|
Asthma | 3 | 1999 | 6274 | 0.070 |
Why?
|
Risk Assessment | 5 | 2023 | 24311 | 0.070 |
Why?
|
Data Display | 1 | 2007 | 174 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2019 | 4417 | 0.070 |
Why?
|
Cesarean Section | 1 | 2016 | 1414 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2239 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2016 | 2780 | 0.070 |
Why?
|
Lung Diseases, Obstructive | 2 | 2000 | 311 | 0.070 |
Why?
|
Family Practice | 1 | 2009 | 510 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4453 | 0.070 |
Why?
|
Energy Intake | 1 | 2014 | 2141 | 0.070 |
Why?
|
Antihypertensive Agents | 2 | 2014 | 2028 | 0.070 |
Why?
|
Muscle Strength | 1 | 2011 | 641 | 0.070 |
Why?
|
Life Style | 2 | 2017 | 3929 | 0.070 |
Why?
|
Bone Nails | 1 | 2008 | 220 | 0.070 |
Why?
|
Fourier Analysis | 1 | 2007 | 441 | 0.070 |
Why?
|
Postural Balance | 1 | 2011 | 638 | 0.070 |
Why?
|
Femoral Neck Fractures | 1 | 2008 | 143 | 0.070 |
Why?
|
Child, Preschool | 6 | 2014 | 42623 | 0.070 |
Why?
|
Femur Neck | 1 | 2008 | 319 | 0.070 |
Why?
|
Models, Animal | 1 | 2013 | 2126 | 0.070 |
Why?
|
Genomics | 2 | 2021 | 5909 | 0.070 |
Why?
|
Placebos | 1 | 2010 | 1668 | 0.070 |
Why?
|
Age Factors | 9 | 2014 | 18478 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2018 | 1937 | 0.070 |
Why?
|
Self Efficacy | 1 | 2010 | 651 | 0.070 |
Why?
|
Intracranial Aneurysm | 1 | 2016 | 1318 | 0.070 |
Why?
|
Regional Blood Flow | 1 | 2009 | 1502 | 0.070 |
Why?
|
Employer Health Costs | 1 | 2005 | 21 | 0.060 |
Why?
|
Drug Interactions | 1 | 2010 | 1421 | 0.060 |
Why?
|
Young Adult | 9 | 2019 | 60045 | 0.060 |
Why?
|
Aortic Coarctation | 1 | 2008 | 278 | 0.060 |
Why?
|
Computer Graphics | 1 | 2007 | 338 | 0.060 |
Why?
|
Blood Flow Velocity | 1 | 2009 | 1377 | 0.060 |
Why?
|
Private Sector | 1 | 2009 | 395 | 0.060 |
Why?
|
Internal Medicine | 1 | 1993 | 1056 | 0.060 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1629 | 0.060 |
Why?
|
Neuropsychological Tests | 4 | 2021 | 7134 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 4 | 2022 | 36840 | 0.060 |
Why?
|
Natriuretic Peptides | 1 | 2006 | 156 | 0.060 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2008 | 477 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 1 | 2010 | 959 | 0.060 |
Why?
|
Selection Bias | 1 | 2007 | 360 | 0.060 |
Why?
|
Lod Score | 2 | 2003 | 600 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1299 | 0.060 |
Why?
|
Animals | 10 | 2023 | 169418 | 0.060 |
Why?
|
Bone Screws | 1 | 2008 | 534 | 0.060 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2016 | 1482 | 0.060 |
Why?
|
Sex Factors | 8 | 2014 | 10647 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2007 | 357 | 0.060 |
Why?
|
Genetic Markers | 3 | 2007 | 2604 | 0.060 |
Why?
|
Socioeconomic Factors | 5 | 2015 | 7863 | 0.060 |
Why?
|
Animals, Newborn | 1 | 2010 | 2696 | 0.060 |
Why?
|
Telecommunications | 1 | 2004 | 79 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9507 | 0.060 |
Why?
|
Airway Obstruction | 1 | 2009 | 672 | 0.060 |
Why?
|
Mouth Breathing | 1 | 2003 | 24 | 0.060 |
Why?
|
Executive Function | 1 | 2012 | 1402 | 0.060 |
Why?
|
Monitoring, Physiologic | 2 | 2009 | 1795 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3038 | 0.060 |
Why?
|
Zimbabwe | 1 | 2004 | 135 | 0.060 |
Why?
|
Workload | 1 | 2009 | 852 | 0.060 |
Why?
|
Physicians, Family | 1 | 2005 | 349 | 0.050 |
Why?
|
Gene Frequency | 2 | 2007 | 3615 | 0.050 |
Why?
|
Infant Nutrition Disorders | 1 | 2004 | 70 | 0.050 |
Why?
|
Infant Food | 1 | 2004 | 139 | 0.050 |
Why?
|
Molecular Imaging | 1 | 2010 | 825 | 0.050 |
Why?
|
Autonomic Nervous System | 1 | 2008 | 709 | 0.050 |
Why?
|
Choice Behavior | 1 | 2009 | 846 | 0.050 |
Why?
|
Sample Size | 2 | 2021 | 851 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2023 | 81834 | 0.050 |
Why?
|
Electroencephalography | 3 | 2013 | 6309 | 0.050 |
Why?
|
Finland | 1 | 2024 | 609 | 0.050 |
Why?
|
Solar Activity | 1 | 2023 | 44 | 0.050 |
Why?
|
Regression Analysis | 2 | 2003 | 6353 | 0.050 |
Why?
|
Glucose Tolerance Test | 3 | 2015 | 1181 | 0.050 |
Why?
|
Waist Circumference | 2 | 2018 | 935 | 0.050 |
Why?
|
Hospitalization | 4 | 2024 | 10845 | 0.050 |
Why?
|
Residential Treatment | 1 | 2023 | 112 | 0.050 |
Why?
|
Computer Communication Networks | 1 | 2004 | 295 | 0.050 |
Why?
|
Quality Control | 2 | 2021 | 835 | 0.050 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2003 | 247 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1629 | 0.050 |
Why?
|
Mesenchymal Stem Cells | 2 | 2010 | 1671 | 0.050 |
Why?
|
Double-Blind Method | 5 | 2019 | 12450 | 0.050 |
Why?
|
Proteins | 1 | 2017 | 6008 | 0.050 |
Why?
|
Sick Sinus Syndrome | 1 | 2002 | 51 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2010 | 952 | 0.050 |
Why?
|
Insurance, Health | 1 | 2014 | 2513 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 2258 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1085 | 0.050 |
Why?
|
Infant | 5 | 2015 | 36497 | 0.050 |
Why?
|
Internship and Residency | 2 | 1993 | 5952 | 0.050 |
Why?
|
Veterans Health | 1 | 2023 | 215 | 0.050 |
Why?
|
Minnesota | 2 | 1993 | 338 | 0.050 |
Why?
|
Outpatients | 1 | 2010 | 1607 | 0.050 |
Why?
|
E-Selectin | 1 | 2024 | 578 | 0.050 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2002 | 229 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 1992 | 1605 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2915 | 0.050 |
Why?
|
Isodesmosine | 2 | 1998 | 6 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2016 | 15460 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2016 | 26395 | 0.050 |
Why?
|
Fracture Fixation, Internal | 1 | 2008 | 981 | 0.050 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2001 | 109 | 0.050 |
Why?
|
Preventive Medicine | 1 | 2003 | 245 | 0.050 |
Why?
|
Disease Progression | 2 | 2011 | 13655 | 0.050 |
Why?
|
Residence Characteristics | 3 | 2013 | 2119 | 0.050 |
Why?
|
Child | 7 | 2012 | 80863 | 0.050 |
Why?
|
Caveolin 1 | 1 | 2022 | 255 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2019 | 4622 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4425 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Adolescent | 8 | 2019 | 89168 | 0.040 |
Why?
|
Students | 1 | 2010 | 1751 | 0.040 |
Why?
|
Motivation | 1 | 2010 | 2034 | 0.040 |
Why?
|
Community Health Services | 1 | 2005 | 659 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Cotinine | 1 | 2000 | 207 | 0.040 |
Why?
|
Alcoholism | 1 | 2011 | 1993 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7451 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 267 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2003 | 501 | 0.040 |
Why?
|
Linkage Disequilibrium | 2 | 2019 | 1998 | 0.040 |
Why?
|
Blotting, Southern | 1 | 2000 | 777 | 0.040 |
Why?
|
Acute Disease | 2 | 2000 | 7246 | 0.040 |
Why?
|
Depression | 4 | 2017 | 8235 | 0.040 |
Why?
|
Hyperlipidemias | 1 | 2004 | 773 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2023 | 738 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 326 | 0.040 |
Why?
|
Body Weight | 4 | 2015 | 4630 | 0.040 |
Why?
|
Brain | 3 | 2022 | 27438 | 0.040 |
Why?
|
Self Report | 2 | 2022 | 3771 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4713 | 0.040 |
Why?
|
Cadaver | 1 | 2003 | 1362 | 0.040 |
Why?
|
Aggression | 1 | 2003 | 750 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4737 | 0.040 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 1 | 2018 | 19 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2023 | 937 | 0.040 |
Why?
|
Proteinuria | 1 | 2001 | 613 | 0.040 |
Why?
|
Blood Cells | 1 | 2000 | 308 | 0.040 |
Why?
|
Electrooculography | 1 | 1998 | 113 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12174 | 0.040 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2017 | 32 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2561 | 0.040 |
Why?
|
Arizona | 1 | 2018 | 108 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2000 | 656 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2010 | 4052 | 0.040 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2017 | 60 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2007 | 2483 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 136 | 0.040 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 264 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2000 | 2228 | 0.040 |
Why?
|
Early Diagnosis | 2 | 2016 | 1196 | 0.040 |
Why?
|
Health Care Reform | 1 | 2006 | 1256 | 0.040 |
Why?
|
Cause of Death | 1 | 2008 | 3727 | 0.040 |
Why?
|
Models, Statistical | 2 | 2014 | 5103 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2001 | 629 | 0.040 |
Why?
|
Patient Discharge | 2 | 2023 | 3471 | 0.040 |
Why?
|
HIV Infections | 1 | 2004 | 17564 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2008 | 2145 | 0.030 |
Why?
|
Airway Resistance | 1 | 1998 | 406 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2000 | 1992 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1230 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2011 | 3985 | 0.030 |
Why?
|
Overweight | 1 | 2008 | 2428 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2004 | 1359 | 0.030 |
Why?
|
Diet | 1 | 2014 | 8098 | 0.030 |
Why?
|
Ultrasonography | 1 | 2009 | 5995 | 0.030 |
Why?
|
Continuity of Patient Care | 2 | 2015 | 1076 | 0.030 |
Why?
|
Health Services Research | 1 | 2024 | 1815 | 0.030 |
Why?
|
Antibiotics, Antitubercular | 1 | 1996 | 99 | 0.030 |
Why?
|
Educational Status | 1 | 2004 | 2519 | 0.030 |
Why?
|
Mental Disorders | 1 | 2016 | 6879 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 9066 | 0.030 |
Why?
|
Bronchial Provocation Tests | 1 | 1996 | 216 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2006 | 2258 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9382 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1542 | 0.030 |
Why?
|
Methacholine Chloride | 1 | 1996 | 220 | 0.030 |
Why?
|
Pollen | 1 | 1996 | 81 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1760 | 0.030 |
Why?
|
Models, Genetic | 2 | 2003 | 3442 | 0.030 |
Why?
|
Small-Area Analysis | 1 | 1995 | 52 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1648 | 0.030 |
Why?
|
Organ Specificity | 1 | 2000 | 1972 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 2000 | 690 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 506 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 692 | 0.030 |
Why?
|
Cromolyn Sodium | 1 | 1995 | 78 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3237 | 0.030 |
Why?
|
Heart | 1 | 2008 | 4451 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2030 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2000 | 1749 | 0.030 |
Why?
|
Pregnancy | 3 | 2016 | 30179 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2019 | 835 | 0.030 |
Why?
|
Amino Acids | 2 | 1998 | 1714 | 0.030 |
Why?
|
Neurosurgical Procedures | 2 | 2016 | 2097 | 0.030 |
Why?
|
Rifampin | 1 | 1996 | 345 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2000 | 828 | 0.030 |
Why?
|
Length of Stay | 3 | 2016 | 6521 | 0.030 |
Why?
|
Heterozygote | 1 | 2021 | 2792 | 0.030 |
Why?
|
Bone Marrow | 1 | 2004 | 2929 | 0.030 |
Why?
|
Menopause | 1 | 2002 | 1651 | 0.030 |
Why?
|
Massachusetts | 2 | 2004 | 8908 | 0.030 |
Why?
|
Nasal Cavity | 1 | 2016 | 309 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2019 | 1032 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2004 | 6856 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2003 | 3484 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2014 | 297 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1813 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4586 | 0.030 |
Why?
|
Bacteroides fragilis | 1 | 2014 | 250 | 0.030 |
Why?
|
Dust | 1 | 1996 | 488 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4249 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4362 | 0.030 |
Why?
|
Research | 1 | 2021 | 1984 | 0.030 |
Why?
|
Hypersensitivity, Immediate | 1 | 1996 | 350 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4138 | 0.030 |
Why?
|
Diet, Fat-Restricted | 1 | 2015 | 329 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2000 | 2415 | 0.030 |
Why?
|
Research Design | 5 | 2007 | 6217 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1058 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2003 | 22293 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10358 | 0.020 |
Why?
|
Cost of Illness | 1 | 2002 | 1960 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3922 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 937 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1991 | 113 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2014 | 252 | 0.020 |
Why?
|
Parturition | 1 | 2016 | 453 | 0.020 |
Why?
|
Walking | 1 | 2019 | 1202 | 0.020 |
Why?
|
Debridement | 1 | 2014 | 494 | 0.020 |
Why?
|
Cardiac Imaging Techniques | 1 | 2014 | 281 | 0.020 |
Why?
|
Multivariate Analysis | 4 | 2009 | 12096 | 0.020 |
Why?
|
Prosthesis Design | 2 | 2009 | 2126 | 0.020 |
Why?
|
Quality Improvement | 2 | 2018 | 3858 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2022 | 4780 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2004 | 3202 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2014 | 542 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2399 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2013 | 441 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 712 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 2016 | 592 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1755 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2007 | 1797 | 0.020 |
Why?
|
Algorithms | 2 | 2008 | 14158 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3665 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4213 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2016 | 1173 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1996 | 846 | 0.020 |
Why?
|
Decision Making | 1 | 2004 | 3961 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2014 | 745 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2000 | 5904 | 0.020 |
Why?
|
Aerosols | 1 | 1992 | 637 | 0.020 |
Why?
|
Boston | 3 | 2001 | 9361 | 0.020 |
Why?
|
Dietary Proteins | 1 | 2014 | 960 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1969 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 6978 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2007 | 11515 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2010 | 408 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1343 | 0.020 |
Why?
|
Bronchi | 1 | 1993 | 847 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6537 | 0.020 |
Why?
|
Polyesters | 1 | 2010 | 375 | 0.020 |
Why?
|
Survival Rate | 3 | 2009 | 12875 | 0.020 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 1996 | 938 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2858 | 0.020 |
Why?
|
Advisory Committees | 1 | 2012 | 797 | 0.020 |
Why?
|
Preoperative Period | 1 | 2010 | 564 | 0.020 |
Why?
|
Fontan Procedure | 1 | 2014 | 805 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2656 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2003 | 3742 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2002 | 2969 | 0.020 |
Why?
|
Minority Groups | 1 | 1995 | 1215 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6606 | 0.020 |
Why?
|
Retroviridae | 1 | 2010 | 850 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3408 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4285 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2013 | 1680 | 0.020 |
Why?
|
Kidney | 1 | 2003 | 7064 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2010 | 20231 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2103 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20762 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2009 | 848 | 0.020 |
Why?
|
Urban Population | 1 | 1995 | 2047 | 0.020 |
Why?
|
Family | 1 | 1998 | 3208 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 1996 | 1764 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3546 | 0.020 |
Why?
|
Physical Fitness | 1 | 2011 | 744 | 0.020 |
Why?
|
Financing, Personal | 1 | 2009 | 310 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2186 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 1509 | 0.020 |
Why?
|
Air Pollutants | 1 | 2000 | 2905 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1995 | 1891 | 0.020 |
Why?
|
Activities of Daily Living | 2 | 2007 | 2433 | 0.020 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2006 | 105 | 0.020 |
Why?
|
Decision Trees | 1 | 2007 | 510 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 595 | 0.020 |
Why?
|
Habits | 1 | 2006 | 147 | 0.020 |
Why?
|
Vagus Nerve | 1 | 2008 | 460 | 0.020 |
Why?
|
Sleep Arousal Disorders | 1 | 2005 | 12 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1833 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 521 | 0.020 |
Why?
|
Medication Errors | 1 | 1991 | 783 | 0.020 |
Why?
|
Brain Mapping | 1 | 2020 | 6740 | 0.020 |
Why?
|
Orthopedic Procedures | 1 | 2015 | 1280 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2000 | 4533 | 0.020 |
Why?
|
Specialization | 1 | 2010 | 782 | 0.020 |
Why?
|
Hepatectomy | 1 | 2009 | 588 | 0.020 |
Why?
|
Lactic Acid | 1 | 2010 | 1140 | 0.020 |
Why?
|
Observation | 1 | 2007 | 311 | 0.020 |
Why?
|
Genital Diseases, Female | 1 | 2006 | 193 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2072 | 0.010 |
Why?
|
Cost Savings | 1 | 2010 | 916 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11206 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 1993 | 1359 | 0.010 |
Why?
|
Mechanotransduction, Cellular | 1 | 2009 | 542 | 0.010 |
Why?
|
Feasibility Studies | 2 | 2010 | 5308 | 0.010 |
Why?
|
Body Constitution | 1 | 2004 | 273 | 0.010 |
Why?
|
Body Composition | 1 | 2013 | 2455 | 0.010 |
Why?
|
Introns | 1 | 2007 | 970 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8559 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3635 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2819 | 0.010 |
Why?
|
Affect | 1 | 2011 | 1498 | 0.010 |
Why?
|
Tissue Scaffolds | 1 | 2010 | 948 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11930 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2004 | 384 | 0.010 |
Why?
|
Poverty | 1 | 1995 | 2719 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4202 | 0.010 |
Why?
|
Drug Therapy | 1 | 2006 | 504 | 0.010 |
Why?
|
Polymers | 1 | 2010 | 1631 | 0.010 |
Why?
|
Program Evaluation | 1 | 1991 | 2508 | 0.010 |
Why?
|
Knee Joint | 1 | 2011 | 1683 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1337 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1989 | 1894 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5767 | 0.010 |
Why?
|
Therapy, Computer-Assisted | 1 | 2004 | 265 | 0.010 |
Why?
|
Sex Distribution | 1 | 2007 | 2286 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5371 | 0.010 |
Why?
|
SEER Program | 1 | 2007 | 1476 | 0.010 |
Why?
|
Job Satisfaction | 1 | 2006 | 549 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 971 | 0.010 |
Why?
|
Mice | 2 | 2010 | 82045 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1989 | 2702 | 0.010 |
Why?
|
Radiography | 2 | 2008 | 6995 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2009 | 1408 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8373 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1989 | 3169 | 0.010 |
Why?
|
Terminal Care | 2 | 2003 | 1773 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3682 | 0.010 |
Why?
|
Societies, Medical | 1 | 2012 | 3955 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3438 | 0.010 |
Why?
|
Schizophrenia | 1 | 2019 | 6986 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2006 | 1139 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2005 | 1670 | 0.010 |
Why?
|
Palliative Care | 1 | 2015 | 3644 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6278 | 0.010 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1999 | 144 | 0.010 |
Why?
|
Lung Volume Measurements | 1 | 2000 | 383 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9642 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2437 | 0.010 |
Why?
|
Mammography | 1 | 2009 | 2436 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 13026 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2004 | 749 | 0.010 |
Why?
|
Patient Admission | 1 | 2006 | 1370 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3713 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23638 | 0.010 |
Why?
|
Family Health | 1 | 2003 | 1256 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1989 | 4362 | 0.010 |
Why?
|
Licensure | 1 | 1998 | 127 | 0.010 |
Why?
|
Nephrotic Syndrome | 1 | 2001 | 382 | 0.010 |
Why?
|
Hysterectomy | 1 | 2003 | 863 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1996 | 205 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7471 | 0.010 |
Why?
|
Creatinine | 1 | 2001 | 1915 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2009 | 4948 | 0.010 |
Why?
|
Genetics, Medical | 1 | 1998 | 334 | 0.010 |
Why?
|
Isoniazid | 1 | 1996 | 288 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2339 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2006 | 2913 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11249 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19041 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 2173 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1989 | 3623 | 0.010 |
Why?
|
Electromyography | 1 | 1998 | 1399 | 0.010 |
Why?
|
Bronchial Fistula | 1 | 1993 | 83 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11674 | 0.010 |
Why?
|
Pleural Diseases | 1 | 1993 | 138 | 0.010 |
Why?
|
Body Height | 1 | 1998 | 1568 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2001 | 2705 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1989 | 5192 | 0.010 |
Why?
|
Rupture | 1 | 1993 | 444 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2006 | 3245 | 0.010 |
Why?
|
Fistula | 1 | 1993 | 213 | 0.010 |
Why?
|
Teaching | 1 | 1998 | 1174 | 0.010 |
Why?
|
Pilot Projects | 1 | 2004 | 8730 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2040 | 0.010 |
Why?
|
Cell-Free System | 1 | 1989 | 340 | 0.000 |
Why?
|
Growth Inhibitors | 1 | 1989 | 375 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1996 | 6320 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1989 | 13708 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1989 | 2126 | 0.000 |
Why?
|
Lymphocytes | 1 | 1989 | 2611 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1989 | 6527 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1989 | 8051 | 0.000 |
Why?
|